Skip to main content

Advertisement

Log in

The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in japan, using ca19-9 and elastase-1 or ultrasonography

  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

To investigate the possibility of detecting carcinomas of the pancreas at an early stage by mass screening of persons without symptoms or by screening the outpatients with gastrointestinal complaints or jaundice, we performed a multicentral study of the mass screening of 10,162 persons at five local areas and of the outpatient screening of 4506 at 17 hospitals for pancreatic cancer in Japan for two years from 1984 to 1985, using serum CA19-9 and elastase-1 determinations or ultrasonography.

Mass screening of 10,162 persons over 40 years old found only four (0.04%) cases of pancreatic cancer, including one case that was curatively treated. According to the screening of 4506 outpatients with gastrointestinal complaints or icterus, 85 (1.9%) patients were found to have pancreatic cancer. Of these 85 patients, 28 could undergo curative treatment. In addition to them, 73 (1.6%) patients with other digestive organ cancer were found. Our results suggest that the mass screening of persons without symptoms is not worthwhile in the early detection of pancreatic cancer, but outpatient screening is useful for detecting curative cancers of the pancreas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hayakawa T, Kondo T, Shibata T, Hamano H, Kitagawa M, Sakai Y, Ono H. Sensitive serum markers for detecting pancreatic cancer. Cancer 1988; 61: 1827–1831.

    Article  PubMed  CAS  Google Scholar 

  2. Stenberg WM, Gelfand R, Anderson KK, Glenn J, Kurtzman SH, Sindelar WF, Toskes PP. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90: 343–349.

    Google Scholar 

  3. Wang T-H, Lin J-T, Chen D-S, Shen J-C, Sung J-L. Noninvasive diagnosis of advancedpancreatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9. Pancreas 1986; 1: 219–223.

    Article  PubMed  CAS  Google Scholar 

  4. Ohyanagi H, Ishida T, Uesaka K, Ishida H, Yamamoto M, Okumura S, Saitoh Y, Yamanaka R, Kobayashi T, Fukuyama K. Immunological and physicochemical properties of new tumor marker for pancreatic cancer, KM01, detected by monoclonal antibody. Jap, J. Gastroenterol. 1985; 82: 1572–1579.

    CAS  Google Scholar 

  5. Hisamichi S. Public health and mass screening for gastric cancer. J. Gastroenterol. Mass Survey. 1984; 64: 83–90.

    Google Scholar 

  6. Frebourg T, Bercoff E, Manchon N, Senant J, Basuyau J-P, Breton P, Janvresse A, Brunelle P, Bourreille J. The evaluation of CA19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients. Cancer 1988; 62: 2287–2290.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Homma, T., Tsuchiya, R. The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in japan, using ca19-9 and elastase-1 or ultrasonography. Int J Pancreatol 9, 119–124 (1991). https://doi.org/10.1007/BF02925587

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02925587

Key Words

Navigation